title: [Individual schedule of administration of aminoglycosides with reference to anatomo-physiological and pathological factors].
abstract: Potentiality of designing individual dosage of sisomicin and gentamicin in regard to "patient factors" was estimated. 62 adult patients with various pulmonary diseases at the background of volemic disorders of diverse degrees were treated with the aminoglycosides under monitoring of their blood levels. Concentrations of sisomicin and gentamicin in serum 1, 3 and 6 hours after their single administration in a dose of 1 mg/kg were determined by HELC. The antibiotic pharmacokinetics was characterized by pronounced individual variability. The ratio of the difference between the upper and lower confidence limits to the average values of the steady-state volume of distribution, the total clearance and the mean residence time amounted to 70, 60 and 57 per cent respectively. To elucidate the cause of the variability multiple correlation analysis of the pharmacokinetic parameters by the "patient factors" was performed. The highest coefficient of the multiple correlation (r = 0.690) defined relation between the aminoglycoside concentration 1 hour after the injection and the hematocrit, globular volume and phase of the volemic disorders which was expressed in coded variables. The coefficient of the multiple correlation between the total clearance and the body surface area, concentrations of creatinine and urea in serum, hematocrit, circulating blood volume and the phase of the volemic disorders was equal to 0.439. Therefore, the consideration of the above factors allowed to explain only 20 per cent of the observed individual variability of the pharmacokinetic parameters. In this connection mediated prediction of total clearance and subsequently individual dosage of the aminoglycosides by the "patient factors" was expedient only until the primary data on the pharmacokinetic monitoring were obtained.
authors.forename: A A
authors.initials: AA
authors.lastname: Firsov
authors.forename: L B
authors.initials: LB
authors.lastname: Kashina
authors.forename: G I
authors.initials: GI
authors.lastname: Lukomskiĭ
authors.forename: M E
authors.initials: ME
authors.lastname: Alekseeva
authors.forename: K K
authors.initials: KK
authors.lastname: Manuĭlov
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001810:Blood Volume / Q000187:drug effects; D004334:Drug Administration Schedule; D005839:Gentamicins / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006400:Hematocrit; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012853:Sisomicin / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D005839:Gentamicins; D012853:Sisomicin
vernacular_title: Individualizatsiia skhem vvedenia aminoglikozidov s uchetom anatomo-fiziologicheskikh i patologicheskikh faktorov.